Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suramin + CAB in Untreated Poor Prognosis Prostate Carcinoma
NCT00001266Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 1990
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of suramin in prostate carcinoma, sponsored by National Cancer Institute. Primary endpoint: Response Rate. Started Oct 1990; status: completed.
02
Drugs
suramin
03
Conditions
prostate carcinoma
Beyond the preview
Go deeper on NCT00001266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001266.